Preferential induction of apoptosis for primary human leukemic stem cells. - Wikidata - wikimedia - TriplyDB

Preferential induction of apoptosis for primary human leukemic stem cells.

Preferential induction of apoptosis for primary human leukemic stem cells.

http://www.wikidata.org/entity/Q34415832

about

Salinomycin as a drug for targeting human cancer stem cells The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells Phenotypic characterization of human colorectal cancer stem cells The NF-κB Pathway and Cancer Stem Cells Therapies targeting cancer stem cells: Current trends and future challenges Concise review: Leukemia stem cells in personalized medicine Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities Feverfew: weeding out the root of leukaemia Targeting NF-kappaB in hematologic malignancies Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice.Molecular markers in prostate cancer. Part I: predicting lethality.Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model Cancer stem cell-directed therapies: recent data from the laboratory and clinic.A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels.p53 regulates hematopoietic stem cell quiescence.Identification and targeting of cancer stem cells.The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.Interleukin-3 receptor in acute leukemia.Targeting the osteosarcoma cancer stem cell A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in Acute Myeloid Leukaemia.A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.Will cancer stem cells provide new therapeutic targets?An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential.Right on target: eradicating leukemic stem cells.Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.Novel agents for the treatment of childhood acute leukemia.Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis.miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.Breast cancer cell line MCF7 escapes from G1/S arrest induced by proteasome inhibition through a GSK-3β dependent mechanism.Considerations for targeting malignant stem cells in leukemia.

P2860

Q21285139-8962662D-4CA7-4F77-AF00-1D8BE4304DAB Q24670343-7D1D01EF-9D87-4C25-A9F2-C2300CC33030 Q24674126-F6899F3F-5433-4F44-97A2-FA8ACC200CB2 Q26750605-098A205D-BD1A-4747-9EDE-17322F03C6DC Q26777880-65A99946-D5F4-4F5D-AADE-47CF2B416BBA Q26995268-C0A63CBA-E160-46A1-B2E2-7244B681E89C Q27309004-C882124D-9F82-4154-AC9C-14E811AAB1F0 Q28071384-652C2AAB-DB19-4885-B125-F9F9D3617F21 Q28268808-E8BABE9B-82F8-4102-AC7F-A2C898F323F6 Q28299055-3F8415D2-53A8-48A7-B694-E09D70B90DA6 Q30300790-5BE0FA24-FCB1-4C57-9794-66053FEBCA87 Q30373669-515F49CD-99D5-45CC-91E6-D1F4A2995549 Q31147913-5F58E57B-780E-4665-9B32-16ADA4E12975 Q33338039-1EB43C51-A62C-4D00-A851-1A35CD1BDEA9 Q33391372-418B6D8C-F8D0-4EB5-B060-958C63BD4E44 Q33630851-BE912623-BA66-4CC0-8A38-89434309B51C Q33714013-A52A4362-0DA3-4F5B-A068-CA9C2D55FC51 Q33732098-CB2EB26A-33D3-410F-B34C-42AB9850D334 Q33921460-E5368A29-DAB5-4B0E-B238-A60D2553F13A Q34176804-AFFD196E-A47A-455E-959A-22A7FE356B07 Q34230583-31F8C25B-3AB9-4CC5-A2B2-6A16EB8BEA4C Q34283145-79E291D9-951D-4268-B24E-F8497B02405B Q34335524-0927B3D4-0E1C-4CC4-8454-7935E0CE10A1 Q34372200-99AE09CC-A260-4CD9-9C0C-D1F10B1A9C66 Q34421932-1F4C9E00-067F-4D15-A84C-9EA2425DA3DB Q34437862-E81A2336-DC71-4285-9206-62EC00DC4C27 Q34551538-B22AC54F-582E-4A53-9B9A-2B26E10A5EA5 Q34582568-899D6A7A-166E-49C2-BE15-A25ECCDB6ED4 Q34585047-236C4069-7A61-4CE8-8765-C577BF9545D6 Q34817365-7CE6A25F-ECF9-49B6-91E1-A32268FA6618 Q34987550-9F04A238-4AA3-4CC5-BD0C-D7AF58749DAA Q35063539-99CC9EB7-D4A0-4A5A-AD98-DFE9C419D9F5 Q35132225-97306233-70E4-459E-8B94-E6338F50C1C4 Q35166848-67602E24-83F3-405F-951A-46B718A8024A Q35192790-B17132D0-9412-464F-916B-95010377AE63 Q35213377-034416C5-4F91-4A7F-9321-F351BD7B42ED Q35369612-C1265A98-A077-4623-A3B7-A4E82B4FC337 Q35456945-123D9C47-1A8F-45C9-ACCB-D21BBC08AA9E Q35569092-3262EB88-0485-4F18-ADDD-F6DB3D727518 Q35692619-D16EC7F7-9EA5-4C6F-B8B7-AC6405F3DD96

P2860

Preferential induction of apoptosis for primary human leukemic stem cells.

http://www.wikidata.org/entity/Q34415832

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Preferential induction of apoptosis for primary human leukemic stem cells.

@ast

Preferential induction of apoptosis for primary human leukemic stem cells.

@en

Preferential induction of apoptosis for primary human leukemic stem cells.

@nl

type

label

Preferential induction of apoptosis for primary human leukemic stem cells.

@ast

Preferential induction of apoptosis for primary human leukemic stem cells.

@en

Preferential induction of apoptosis for primary human leukemic stem cells.

@nl

prefLabel

Preferential induction of apoptosis for primary human leukemic stem cells.

@ast

Preferential induction of apoptosis for primary human leukemic stem cells.

@en

Preferential induction of apoptosis for primary human leukemic stem cells.

@nl

P1433

Q34415832-CB990733-726C-40F6-B34F-1536E0523FF7

P1476

Q34415832-6192F304-5515-446B-AD09-32851314FDE5

P2093

Q34415832-2CBCA94A-43C5-4D07-9AAD-30794C470D53

Q34415832-3A7172EB-0C66-4290-90FD-6E2E81A4A1CC

Q34415832-9B9B115D-B6A1-4081-B6CB-D6032C331325

Q34415832-C0B1F659-8653-4E11-BDEF-CC9FD5336C78

Q34415832-EDA95DEC-ED73-4C3E-AF18-8D1602C84DC4

Q34415832-F506D28A-C71E-47D2-94F1-EF4BD18C75F8

Q34415832-F5FA2D7F-29CE-4485-9F2A-2786EAD2279D

P2860

Q34415832-0027C5A8-DF3D-458D-8DA6-720B12BAC621

Q34415832-02EA7E90-17CC-4BF6-A32A-C63261BF10D0

Q34415832-0D254B97-B1AD-498A-B6EC-A25CDC818AA5

Q34415832-0DEA6EA7-5C71-4B61-B339-A116DD301E7A

Q34415832-102ACEA4-A7AB-44FB-B1EB-D650AEEB3360

Q34415832-28A132F9-CC71-4A6F-9630-778F8F6B521C

Q34415832-2AA1098C-FE33-4411-81AE-D63884BE794B

Q34415832-2B12AE37-EF69-4804-8D23-CA117BA9CDB8

Q34415832-2E4D3587-6AF1-42A6-BB1A-310A9B5BC117

Q34415832-31865945-9C9E-4B75-98DE-0F0B5BE5C6AE

P304

Q34415832-BB958DAA-075E-4AC2-A9B8-9C496C571C64

P31

Q34415832-CBA88DA0-070C-4DD1-8512-A99E5E71EA21

P356

Q34415832-05EFDE85-9936-4FC4-949D-FE4FD02CDF18

P407

Q34415832-62AEC351-D440-4836-B58D-11A5D9B30E49

P433

Q34415832-93449FBB-8CED-4154-B460-A4C97C297E3F

P478

Q34415832-7AFBF5F0-95C5-4CD7-AED8-5ABFC97FF7E6

P577

Q34415832-57BA56C0-620D-4A7A-8F44-C3FC30D232EE

P5875

Q34415832-B5C2F7E2-637D-4C54-A188-5FEBD1F1E00E

P698

Q34415832-459BB387-3354-4A3D-81D5-8D32F0BC378C

P921

Q34415832-AC2C1954-14C4-4FCB-B2A4-A35BB6044CE8

P932

Q34415832-AED8DEEA-0E28-4CD1-991B-3C1E7F4E8E98

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Preferential induction of apoptosis for primary human leukemic stem cells.

@en

P2093

Barry A Grimes

http://www.w3.org/2001/XMLSchema#string

Carol F Swiderski

http://www.w3.org/2001/XMLSchema#string

Craig T Jordan

http://www.w3.org/2001/XMLSchema#string

Dianna S Howard

http://www.w3.org/2001/XMLSchema#string

Monica L Guzman

http://www.w3.org/2001/XMLSchema#string

Randall M Rossi

http://www.w3.org/2001/XMLSchema#string

Stephen J Szilvassy

http://www.w3.org/2001/XMLSchema#string

P2860

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

WAF1, a potential mediator of p53 tumor suppression

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

Nuclear transcription factor-kappaB as a target for cancer drug development

The proteasome: a novel target for cancer chemotherapy

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

NF-kappaB in cancer: from innocent bystander to major culprit

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

P304

16220-16225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.252462599

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11018583

http://www.w3.org/2001/XMLSchema#string

P698

12451177

http://www.w3.org/2001/XMLSchema#string

P921

P932

138592

http://www.w3.org/2001/XMLSchema#string